Multisystem Langerhans Cell Histiocytosis with Fatal Outcome in Adult Patient: A Case Report
Clinical Medicine Research
Volume 6, Issue 4, July 2017, Pages: 139-142
Received: May 21, 2017;
Accepted: Jun. 28, 2017;
Published: Jul. 26, 2017
Views 1973 Downloads 73
Veljko Flego, Department of Pulmonology, Clinical Hospital Centre Rijeka, Rijeka, Croatia
Darian Volaric, Primary Health Care Office, Health Centre of Primorsko-Goranska County, Rijeka, Croatia
Follow on us
Langerhans cell histiocytosis (LCH) is a rare disorder characterized by abnormal proliferation of cells with a Langerhans cell phenotype, which comprises a wide range of clinical presentations. The reported patient is a 55-year old female with multy-sistem LCH and pulmonary tuberculosis. During diagnostic processing, infiltrates of Langerhans cells (S-100+, CD1a+) in the epidermis, intestinal mucosa and bone marrow, were discovered. Transbronchial needle biopsy of the lung revealed non-specific clusters of macrophages (CD68+, CD1a-). Although CD1a was negative, positive CD68, thoracic MSCT and clinical findings indicated pulmonary LCH. Corticosteroid treatment led to significant clinical improvement. Seven months after treatment with corticosteroids the patient developed a spontaneous left-sided pneumothorax. Thoracic HR (high resolution)-MSCT was highly suggestive for active Mycobacterium tuberculosis (MT) infection together with the positive QUANTIFERON-TB test and typical symptoms. One week after starting standard triple antituberculotic therapy the patient developed hypovolemic shock. Despite all medical efforts, the patient died on the thirteenth day of intensive treatment for multiple organ failure.
Langerhans-Cell Histiocytosis, Pulmonary Tuberculosis, Multislice Computed Tomography, Corticosteroids, Multiple Organ Failure
To cite this article
Multisystem Langerhans Cell Histiocytosis with Fatal Outcome in Adult Patient: A Case Report, Clinical Medicine Research.
Vol. 6, No. 4,
2017, pp. 139-142.
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/
) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Shevale V, Ekta K, Snehal T, Geetanjal M. A rare occurrence of Langerhans cell histiocytosis in an adult. Journal of Oral and Maxillofacial Pathology. 2014; 18(3):415-9.
Berres M, Merad M, Allen C. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?. British Journal of Haematology. 2014; 169(1):3-13.
Özen M, Akçakaya N, Camcioğlu Y, Cokugras H, Oz B. Isolated pulmonary Langerhans-cell histiocytosis mimicking miliary tuberculosis. J Pediatr Inf 2009; 3: 135−7.
Juvet S, Hwang D, Downey G. Rare Lung Diseases III: Pulmonary Langerhans’ Cell Histiocytosis. Canadian Respiratory Journal. 2010; 17(3):e55-e62.
Dimitropoulos C, Vamvakaris I, Vassos D, Hamalakis G, Gkogkou C, Kokkini A, Ntanos I. Pulmonary Langerhans’ cell histiocytosis or miliary tuberculosis? Case report and literature review. Arch Hell Med 2011; 28(6): 809–13.
Okutan O, Kartaloglu Z, Ilvan A, Deniz O, Silit E, Gorur R. Active pulmonary tuberculosis in a patient with Langerhans cell histiocytosis. Saudi Med J 2006; 27(3):401–2.
Sharma P, Dhingra K, Sural S, Mandal A, Singh T. Langerhans cell histiocytosis masquerading as tuberculosis: A diagnostic dilemma resulting in inappropriate anti-tubercular therapy. Pediatr Blood Cancer. 2009; 53(1):111-3.
Zhang LMoss J. Genetic studies yield clues to the pathogenesis of Langerhans cell histiocytosis. Eur Respir J. 2016; 47(6):1629-31.
Pfeifer K, Mian A, Adebowale A, Alomari A, Kalra V, Krejci E, Shin MS. Radiographic and Pathologic Manifestations of Uncommon and Rare Pulmonary Lesions. Canadian Association of Radiologists Journal. 2016; 67(2):179-89.
Patne S, Dwivedi S, Katiyar R, Gupta V, Gupta A. Langerhans cell histiocytosis diagnosed by FNAC of lymph nodes. J Can Res Ther. 2015; 11(4):1028.
Routy B, Hoang J, Gruber J. Pulmonary Langerhans Cell Histiocytosis with Lytic Bone Involvement in an Adult Smoker: Regression following Smoking Cessation. Case Reports in Hematology. 2015; 2015: 1-5.
Watanabe R, Tatsumi K, Hashimoto S, Tamakoshi A, Kuriyama T. The Respiratory Failure Research Gr. Clinico-Epidemiological Features of Pulmonary Histiocytosis X. Intern Med. 2001; 40 (10):998-1003.
Suri H, Yi E, Nowakowski G, Vassallo R. Pulmonary langerhans cell histiocytosis. Orphanet Journal of Rare Diseases. 2012; 7 (1):16.
Lian C, Lu Y, Shen S. Langerhans cell histiocytosis in adults: a case report and review of the literature. Oncotarget 2016; 7 (14):18678-83.